A clearer reading
Cannabinol Use in Patients With Insomnia Disorder
Registry metadata, preparation and research links; registration is not proof of benefit.
Registration describes a study. It does not establish benefit, retail product efficacy, vendor quality or current recruitment availability.
The registry record was last updated more than a year before our check. Its sponsor-reported status may be out of date; follow the original record for current information.
NCT05344170 · CBN
- Registry status
- Completed — sponsor-reported
- Phase
- Phase 1 / Phase 2
- Registry results
- No results tables posted in registry
- Study preparation
- ECS 310 CBN in MCT oil compared with matched placebo.
- Population
- Adults with insomnia disorder.
- Registered enrollment
- 20 (actual)
- Lead sponsor
- Woolcock Institute of Medical Research
- First posted
- 2022-04-25
- Registry last update posted
- 2024-02-06
- Sponsor status verified
- 2023-05
- Our source check
- 2026-10-25
Single-night crossover research. The linked paper reported no statistically significant change in its primary wake-after-sleep-onset endpoint.
Read the related research in context.
Related paper coverage is separate from registry-posted results tables.
Related primary paperSuggest a source correction
Copy a note and share it with the person who sent this preview. This page does not send or store your note.